NASDAQ:SABS | EBITDA | SAB Biotherapeutics, Inc.

Complete source-backed ebitda history.

Available history
2020-12-31 to 2026-06-30
Data captured

Historical EBITDA

DateEBITDA
2026-06-30-$22.58M
2026-03-31-$19.27M
2025-12-31-$15.03M
2025-09-30-$11.98M
2025-06-30-$8.93M
2025-03-31-$10.02M
2024-12-31-$9.24M
2024-09-30-$10.41M
2024-06-30-$9.2M
2024-03-31-$9.43M
2023-12-31-$17.95M
2023-09-30-$4.32M
2023-06-30-$5.58M
2023-03-31-$6.5M
2022-12-31-$6.96M
2022-09-30-$6.92M
2022-06-30-$5.79M
2022-03-31-$6.07M
2021-12-31-$6.72M
2021-09-30-$3.62M
2021-06-30-$2.61M
2021-03-31$1.05M

Annual EBITDA

DateEBITDA
2025-12-31-$45.96M
2024-12-31-$38.2M
2023-12-31-$34.42M
2022-12-31-$25.75M
2021-12-31-$11.9M
2020-12-31$20.94M

Research interface only. Not investment advice. Prices are a checked-in snapshot, not live quotes.